New York State Common Retirement Fund Collegium Pharmaceutical, Inc Transaction History
New York State Common Retirement Fund
- $73.9 Billion
- Q3 2024
A detailed history of New York State Common Retirement Fund transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, New York State Common Retirement Fund holds 10,076 shares of COLL stock, worth $328,376. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,076
Previous 13,276
24.1%
Holding current value
$328,376
Previous $427,000
8.9%
% of portfolio
0.0%
Previous 0.0%
Shares
22 transactions
Others Institutions Holding COLL
# of Institutions
249Shares Held
36.2MCall Options Held
100KPut Options Held
21.1K-
Black Rock Inc. New York, NY5.79MShares$189 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.64MShares$85.9 Million1.79% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.35MShares$76.5 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.14MShares$69.8 Million0.15% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.66MShares$54 Million0.1% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $1.11B
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...